Phase 1 33 trials
Phase 1
NCT03441555 May 2018 → Jan 2021 acute myeloid leukemia AbbVie
Completed
No outcome recorded
Phase 1
NCT03563560 May 2018 → Mar 2020 acute myeloid leukemia Sumitomo Pharma Co., Ltd.
Completed
No outcome recorded
Phase 1
NCT03298984 Sep 2017 → Mar 2020 acute myeloid leukemia Sumitomo Pharma America, Inc.
Completed
No outcome recorded
Phase 1
NCT01076556 Apr → Jul 2010 chronic lymphocytic leukemia/small lymphocytic lymphoma , prolymphocytic leukemia National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT00735930 Aug 2008 → Mar 2013 anemia , chronic lymphocytic leukemia/small lymphocytic lymphoma , prolymphocytic leukemia , thrombocytopenia National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00470197 Apr 2007 → Jan 2011 acute erythroid leukemia , acute megakaryoblastic leukemia in adult , acute myeloblastic leukemia with maturation , acute myeloblastic leukemia without maturation +8 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00377104 Sep 2006 → Nov 2012 chronic lymphocytic leukemia/small lymphocytic lymphoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT00324480 Mar 2006 → Apr 2009 cancer of unknown primary site National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00112684 Feb 2006 → Jul 2012 cancer of unknown primary site National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT00278330 Jan 2006 → Oct 2009 acute myeloid leukemia , adult acute lymphoblastic leukemia , blast phase chronic myelogenous leukemia, BCR-ABL1 positive , myelodysplastic syndrome with excess blasts National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00094978 Oct 2004 → May 2013 esophageal cancer , malignant pleural mesothelioma , non-small cell lung carcinoma , small cell carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT00098579 Oct 2004 → Jul 2011 gastrointestinal stromal tumor , soft tissue sarcoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00101231 Oct 2004 → Nov 2012 acute basophilic leukemia , acute megakaryoblastic leukemia in adult , acute myeloblastic leukemia with maturation , acute myeloblastic leukemia without maturation +10 National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT00079352 Apr 2004 → Oct 2007 cancer of unknown primary site National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00082784 Mar 2004 → Oct 2012 MALT lymphoma , Waldenstrom macroglobulinemia , diffuse large B-cell lymphoma , mantle cell lymphoma +3 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00080990 Feb 2004 → Apr 2009 —
National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00072436 Sep 2003 → Mar 2009 cancer of unknown primary site National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00070239 Aug 2003 → Jun 2006 cancer of unknown primary site , hematopoietic and lymphoid system neoplasm National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT00064285 Jun 2003 → ? leukemia Virginia Commonwealth University
Completed
No outcome recorded
Phase 1
NCT00058227 Apr 2003 → Feb 2009 MALT lymphoma , Waldenstrom macroglobulinemia , chronic lymphocytic leukemia/small lymphocytic lymphoma , mantle cell lymphoma +3 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00047307 Aug 2002 → Aug 2008 pancreatic adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00046917 Jul 2002 → Mar 2010 cancer of unknown primary site National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00042874 May 2002 → Jan 2009 cancer of unknown primary site National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00039455 Apr 2002 → Dec 2004 HER2 positive breast carcinoma , male breast carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT00045448 Apr 2002 → Jan 2006 cancer of unknown primary site Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1
NCT00021073 May 2001 → Apr 2006 cancer of unknown primary site National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00012181 Apr 2001 → Jan 2005 Burkitt lymphoma , Ewing sarcoma/peripheral primitive neuroectodermal tumor , Hodgkins lymphoma , cerebellar astrocytoma +13 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00016185 Mar 2001 → Feb 2003 cancer of unknown primary site Barbara Ann Karmanos Cancer Institute
Completed
No outcome recorded
Phase 1
NCT00007917 Jan 2001 → Sep 2010 cancer of unknown primary site National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00006485 Sep 2000 → Dec 2003 cancer of unknown primary site Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1
NCT00003690 Dec 1998 → Sep 2003 breast cancer , cutaneous melanoma , prostate cancer Mayo Clinic
Completed
No outcome recorded
Phase 1
NCT00019344 Aug 1997 → ? lymphoma , prostate cancer , small intestine cancer National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00003004 Jul 1997 → Oct 2001 —
Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Show 23 more trials Phase 1/2 7 trials
Phase 1/2
NCT04493099 Oct 2020 acute myeloid leukemia M.D. Anderson Cancer Center
Withdrawn
No outcome recorded
Stop: Business
Phase 1/2
NCT03593915 Aug 2018 → Aug 2021 myelodysplastic syndrome Sumitomo Pharma America, Inc.
Terminated
No outcome recorded
Stop: Business
Phase 1/2
NCT00445341 Nov 2006 → Apr 2012 lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT00112723 Dec 2005 → Feb 2011 Hodgkin's lymphoma, lymphocytic depletion , Hodgkin's lymphoma, mixed cellularity , MALT lymphoma , Waldenstrom macroglobulinemia +12 National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1/2
NCT00058240 Apr 2003 → Feb 2009 Waldenstrom macroglobulinemia , chronic lymphocytic leukemia/small lymphocytic lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT00016016 Feb 2001 → Nov 2006 acute myeloid leukemia , adult acute lymphoblastic leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT00020332 Oct 2000 → Mar 2003 breast cancer National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2 24 trials · 1 met primary · 1 missed
Phase 2
NCT03969420 Jan 2020 → Apr 2021 acute myeloid leukemia Sumitomo Pharma America, Inc.
Terminated
No outcome recorded
Stop: Business
Phase 2
NCT02520011 Mar 2016 → Feb 2020 acute myeloid leukemia Sumitomo Pharma America, Inc.
Terminated
No outcome recorded
Stop: Enrollment
Phase 2
NCT01349972 Apr 2011 → May 2014 acute erythroid leukemia , acute myeloblastic leukemia with maturation , acute myeloblastic leukemia without maturation , acute myeloid leukemia with 11q23 abnormalities +8 National Cancer Institute (NCI)
Completed
Met primary
Phase 2
NCT00991952 Sep 2009 → Feb 2012 diffuse gastric adenocarcinoma , gastric intestinal type adenocarcinoma , gastroesophageal junction adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00957905 Jun 2009 → Aug 2014 extragonadal nonseminomatous germ cell tumor , extragonadal seminoma , malignant testicular germ cell tumor , ovarian germ cell tumor National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00795002 Nov 2008 → Nov 2010 acute erythroid leukemia , acute megakaryoblastic leukemia in adult , acute myeloblastic leukemia with maturation , acute myeloblastic leukemia without maturation +9 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00634244 Oct 2008 → Sep 2014 acute erythroid leukemia , acute megakaryoblastic leukemia in adult , acute myeloblastic leukemia with maturation , acute myeloblastic leukemia without maturation +7 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00464633 Mar 2007 → Dec 2011 chronic lymphocytic leukemia/small lymphocytic lymphoma Sanofi
Completed
No outcome recorded
Phase 2
NCT00407966 Oct 2006 → Jul 2008 acute basophilic leukemia , acute erythroid leukemia , acute megakaryoblastic leukemia in adult , acute myeloblastic leukemia with maturation +8 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00331682 Mar 2006 → May 2008 pancreatic adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00098371 Apr 2005 → Jun 2009 B-cell chronic lymphocytic leukemia , prolymphocytic leukemia National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT00087282 Jun 2004 → Jul 2006 liver cancer Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 2
NCT00083122 Apr 2004 → Jul 2010 malignant epithelial tumor of ovary , primary peritoneal carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00047203 Sep 2002 → Sep 2006 plasma cell myeloma , refractory plasma cell neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00023894 Jul 2001 → Feb 2006 endometrial cancer Gynecologic Oncology Group
Completed
No outcome recorded
Phase 2
NCT00016939 May 2001 → Apr 2006 renal cell carcinoma SWOG Cancer Research Network
Completed
No outcome recorded
Phase 2
NCT00005971 Jul 2000 → Aug 2001 cutaneous melanoma NCIC Clinical Trials Group
Completed
No outcome recorded
Phase 2
NCT00005974 Jul 2000 → Nov 2002 soft tissue sarcoma NCIC Clinical Trials Group
Completed
No outcome recorded
Phase 2
NCT00006245 Jul 2000 → Aug 2007 esophageal cancer Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 2
NCT00020189 Jun 2000 → Aug 2004 head and neck cancer , thrombotic disease National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00005074 Jan 2000 → Feb 2002 lymphoma NCIC Clinical Trials Group
Completed
No outcome recorded
Phase 2
NCT00003620 Jun 1999 → Jun 2006 B-cell chronic lymphocytic leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00003256 May 1998 → Jul 2002 prostate cancer National Cancer Institute (NCI)
Completed
Missed primary
Phase 2
NCT00003039 Sep 1997 → Apr 2000 lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Show 14 more trials